SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Presti who wrote (283)2/4/1997 2:46:00 PM
From: jeeza   of 1172
 
to bill presti

the underwriter is also the primary market-maker
if he wants to do further business with the company he will get his hints and do the appropriate
in this case...hold down the stock price till debentures are converted..afterall the debentures are held by people close to the management
this does lead to dilution but in CMTR case..we are just seeing 2M shares being added...and I trust the management to put it to good use
it would be nice to know how much of the discount r these debenture holders getting...or how big is the favor which the shareholders are doing to the management..yes we are indirectly lining their pockets

HpChek ...no announcements yet...but it will launch when merck-astra are ready with their stuff

there is good news pending on CMTR...just my IMHO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext